Simultaneous confocal laser endomicroscopy and chromoendoscopy with topical cresyl violet.
BACKGROUND
Confocal laser endomicroscopy (CLE) has been shown to reliably predict histology during ongoing endoscopy. To unmask lesions for CLE, chromoendoscopy has been mandated. Usually fluorescein then serves as a contrast agent for CLE, but it does not allow direct nuclear visualization, must be injected, leads to a transient skin discoloration, and may have allergic side effects.


OBJECTIVE
To establish a single topical dye, cresyl violet (CV), for simultaneous chromoendoscopy and in vivo CLE of the lower GI tract.


METHODS
Animal preclinical study, prospective clinical trial.


METHODS
Mainz University Clinic (tertiary care center). PATIENTS, METHODS, AND INTERVENTIONS: To establish the staining characteristics and optimal concentration of CV, the ileum and colon of 7 BL6 mice were stained with CV (0.1%-2%), and in vivo confocal imaging was performed with FIVE1. In a subsequent clinical trial, 67 sites in 36 patients were topically stained with CV 0.13%, and subsurface serial images were generated at different depths with an endomicroscope.


METHODS
Prediction of histology according to the Mainz confocal classification and nuclear visualization with topical CV.


RESULTS
Endomicroscopy with topical CV yielded (sub-)cellular details of normal mucosa, and regenerative and neoplastic changes at variable imaging depths in high resolution comparable to those with intravenous fluorescein. By cytoplasmic enrichment of CV, nuclear morphology could be negatively visualized. Reliable differentiation of nonneoplastic versus neoplastic changes during ongoing endoscopy and a high interobserver agreement based on the microscopic images generated in vivo could be achieved.


CONCLUSIONS
Single-center study, nonrandomized, limited number of patients.


CONCLUSIONS
CV can be applied topically and allows simultaneous chromoendoscopy and endomicroscopy with accurate prediction of histology with visualization of nuclear morphology. It may therefore be a single-agent alternative to chromoendoscopy and fluorescein in endomicroscopy.
Goetz
Martin
M
I. Medical Clinic, University of Mainz, Mainz, Germany.
Toermer
Tanja
T
Vieth
Michael
M
Dunbar
Kerry
K
Hoffman
Arthur
A
Galle
Peter R
PR
Neurath
Markus F
MF
Delaney
Peter
P
Kiesslich
Ralf
R
D000287:Administration, Topical; D000818:Animals; D048588:Benzoxazines; D002278:Carcinoma in Situ / Q000175:diagnosis; D003106:Colon / Q000473:pathology; D003110:Colonic Neoplasms / Q000175:diagnosis*; D004396:Coloring Agents / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D004195:Disease Models, Animal; D016099:Endoscopy, Gastrointestinal / Q000379:methods*; D005260:Female; D006801:Humans; D007078:Ileal Neoplasms / Q000175:diagnosis*; D007082:Ileum / Q000473:pathology; D007413:Intestinal Mucosa / Q000473:pathology*; D051379:Mice; D018613:Microscopy, Confocal / Q000379:methods*; D008875:Middle Aged; D010078:Oxazines / Q000008:administration & dosage*; D010865:Pilot Projects; D015203:Reproducibility of Results
D048588:Benzoxazines; D004396:Coloring Agents; D010078:Oxazines; C028911:cresyl violet